Article discusses FDA’s guidance on accelerated approval, suggesting improvements for trial expectations and safety management.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kodan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from JAMA